These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6147203)

  • 1. [Dopaminergic receptors in the brain].
    Alexandrová M
    Cesk Fysiol; 1984; 33(3):227-40. PubMed ID: 6147203
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain receptors for dopamine and neuroleptics.
    Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
    Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual regulation of adenylate cyclase activity and hormone release in the intermediate lobe of the rat pituitary gland: evidence for the involvement of membrane components of the stimulatory beta 2-adrenergic system and of the inhibitory D-2 dopaminergic system.
    Cote TE; Frey EA; Sekura RD; Kebabian JW
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():151-67. PubMed ID: 2988295
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine receptors in the central nervous system.
    Creese I; Sibley DR; Hamblin MW; Leff SE
    Adv Biochem Psychopharmacol; 1983; 36():125-34. PubMed ID: 6344562
    [No Abstract]   [Full Text] [Related]  

  • 6. The complexity of dopamine receptors and psychopharmacotherapy in children.
    Guérin P; Barthélémy C; Garreau B; Héraut J; Muh JP; Lelord G
    Acta Paedopsychiatr; 1993; 56(2):139-51. PubMed ID: 7510920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term neuroleptic treatment on dopamine tuberoinfundibular system: development of tolerance?
    Naber D; Fischer H; Ackenheil M
    Commun Psychopharmacol; 1979; 3(1):59-65. PubMed ID: 38032
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
    Richelson E
    J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive changes in brain dopamine function as a result of neuroleptic treatment.
    Jenner P; Marsden CD
    Adv Neurol; 1988; 49():417-31. PubMed ID: 2894127
    [No Abstract]   [Full Text] [Related]  

  • 11. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
    Annunziato L; Quattrone A; Schettini G; Di Renzo G
    Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
    [No Abstract]   [Full Text] [Related]  

  • 12. Maturational aspects of the dopaminergic system: ontogenesis of high affinity dopamine binding to neural membrane fragments of the rat brain.
    Karakiulakis G; Paradelis AG; Papaioannidou PG; Thomas PJ
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):685-94. PubMed ID: 6672486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The classification of dopamine receptors: relationship to radioligand binding.
    Creese I; Sibley DR; Hamblin MW; Leff SE
    Annu Rev Neurosci; 1983; 6():43-71. PubMed ID: 6220666
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of [3H]-neuroleptics to dopamine receptors on rat cerebral membranes [proceedings].
    Howlett DR; Nahorski SR
    Br J Pharmacol; 1978 Mar; 62(3):396P. PubMed ID: 25103
    [No Abstract]   [Full Text] [Related]  

  • 15. Central nervous system dopamine receptors.
    Creese I
    Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropharmacological intervention on the pituitary-hypothalamic relationship.
    Tuomisto J
    Ann Clin Res; 1978; 10(3):120-32. PubMed ID: 31130
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic drugs and the sigma receptor.
    Hoffman DW
    Am J Psychiatry; 1990 Aug; 147(8):1093-4. PubMed ID: 1973876
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine receptors and antipsychotic drug response.
    Sunahara RK; Seeman P; Van Tol HH; Niznik HB
    Br J Psychiatry Suppl; 1993 Dec; (22):31-8. PubMed ID: 7906523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 20. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.